Article Detail - JE Part B
Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update (A54386) - R11 - Effective October 1, 2024
Date Posted: September 5, 2024
This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Effective Date: October 1, 2024
Summary of Article Changes:
Under ICD-10 Codes that Support Medical Necessity Group 1: Codes deleted C86.1 and C88.4. Added C83.390 and C83.398. This revision is due to the Annual ICD-10-CM Update and will become effective on 10/1/2024.
Visit the Noridian Active MolDX Billing and Coding Articles and Educational Articles webpage to view the complete listing of coverage articles and articles available in the CMS MCD.